These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 2136919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.
    Baldessarini RJ, Kula NS, Gao Y, Campbell A, Neumeyer JL.
    Neuropharmacology; 1991 Jan; 30(1):97-9. PubMed ID: 1675452
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist.
    Neumeyer JL, Gao YG, Kula NS, Baldessarini RJ.
    J Med Chem; 1990 Dec; 33(12):3122-4. PubMed ID: 2147956
    [No Abstract] [Full Text] [Related]

  • 4. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.
    Gao YG, Baldessarini RJ, Kula NS, Neumeyer JL.
    J Med Chem; 1990 Jun; 33(6):1800-5. PubMed ID: 1971309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines.
    Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Timmermans PB, Wynberg H, Horn AS.
    Eur J Pharmacol; 1986 May 13; 124(1-2):93-106. PubMed ID: 3720849
    [Abstract] [Full Text] [Related]

  • 11. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T, Ström P, de Paulis T, Stensland B, Csöregh I, Lundin K, Hall H, Ogren SO.
    J Med Chem; 1991 Mar 13; 34(3):948-55. PubMed ID: 1672158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E, Bohmaker K, Goldstein M, Schweitzer JW, Friedhoff AJ.
    Eur J Pharmacol; 1985 Mar 12; 109(3):389-94. PubMed ID: 3157587
    [Abstract] [Full Text] [Related]

  • 14. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Horn AS.
    Eur J Pharmacol; 1985 Feb 26; 109(2):229-40. PubMed ID: 3922776
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.
    Wallace RA, Wallace L, Harrold M, Miller D, Uretsky NJ.
    Biochem Pharmacol; 1989 Jun 15; 38(12):2019-25. PubMed ID: 2525907
    [Abstract] [Full Text] [Related]

  • 17. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O, Roncada P, Dall'Olio R, Montanaro N.
    Brain Res; 1988 Jul 12; 455(2):390-3. PubMed ID: 2969768
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.